XGX Pharma ApS: Financial statements 2012
CVR: 32289290
XGX Pharma ApS (CVR 32289290) has filed annual accounts for 2012. In 2012, the company reported a gross profit of DKK 83,774 and a net result of DKK 96,450. Equity amounted to DKK -14,277.
- Gross Profit
- 83,774 kr.
- Profit/Loss
- 96,450 kr.
- Equity
- -14,277 kr.
- Total Assets
- 66,353 kr.
How creditworthy is XGX Pharma ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreAbout XGX Pharma ApS
XGX Pharma ApS is a Danish company of the type Anpartsselskab based in København K, founded in 2009. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Jens-Nikolaj Schøier. The company is owned by Unimedic Pharma AB. The company has 2 employees. In 2025, the company reported a gross profit of DKK 32,338,381 and a net result of DKK 16,074,119 compared with DKK 4,453,433 the year before. Equity amounted to DKK 30,787,180.
